検索結果 61 - 80 結果 / 4,311 検索語 '((((clarification OR clarification) OR purification) OR modifications) OR modification)', 処理時間: 0.17秒 結果の絞り込み
  1. 61

    Chemical Composition and Backbone Modifications Define Deformability of Nucleic Acid Nanoparticles 著者: Laxmi Pandey (18762706)

    出版事項 2025
    “…Finally, different chemical modifications introduced to the strands can be used to fine-tune the mechanical properties of the NANPs.…”
  2. 62

    Uncovering hidden protein modifications with native top-down mass spectrometry 著者: Jack L. Bennett (19428651)

    出版事項 2025
    主題: “…post-translational modifications…”
  3. 63
  4. 64

    Chemical Composition and Backbone Modifications Define Deformability of Nucleic Acid Nanoparticles 著者: Laxmi Pandey (18762706)

    出版事項 2025
    “…Finally, different chemical modifications introduced to the strands can be used to fine-tune the mechanical properties of the NANPs.…”
  5. 65

    Functional impact of PG modifications on colony opacity of <i>S. pneumoniae.</i> 著者: Xiu-Yuan Li (3328056)

    出版事項 2025
    “…<p><b>(A)</b> Illustrative depiction of the two post-synthetic PG modifications. M, <i>N</i>-acetylmuramic acid (NAM). …”
  6. 66

    Chemical Composition and Backbone Modifications Define Deformability of Nucleic Acid Nanoparticles 著者: Laxmi Pandey (18762706)

    出版事項 2025
    “…Finally, different chemical modifications introduced to the strands can be used to fine-tune the mechanical properties of the NANPs.…”
  7. 67

    Chemical Composition and Backbone Modifications Define Deformability of Nucleic Acid Nanoparticles 著者: Laxmi Pandey (18762706)

    出版事項 2025
    “…Finally, different chemical modifications introduced to the strands can be used to fine-tune the mechanical properties of the NANPs.…”
  8. 68
  9. 69
  10. 70
  11. 71
  12. 72

    Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group Modifications 著者: Olasunkanmi O. Olaoye (10131945)

    出版事項 2025
    “…Hydroxamic acid (HA)-based HDAC inhibitors often suffer from poor pharmacokinetic (PK) profiles, limiting their in vivo applications. Cap group modification offers a promising strategy to address these challenges. …”
  13. 73

    Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group Modifications 著者: Olasunkanmi O. Olaoye (10131945)

    出版事項 2025
    “…Hydroxamic acid (HA)-based HDAC inhibitors often suffer from poor pharmacokinetic (PK) profiles, limiting their in vivo applications. Cap group modification offers a promising strategy to address these challenges. …”
  14. 74
  15. 75

    <b>Lossless Altered Histone Modification Analysis System (LAHMAS)</b>m 著者: Jamie Sperger (21646463)

    出版事項 2025
    “…The resultant Lossless Altered Histone Modification Analysis System (LAHMAS) employs a PDMS-silane treated glass surface immersed in silicone oil to facilitate lossless liquid handling and prevent sample evaporation. …”
  16. 76
  17. 77
  18. 78
  19. 79
  20. 80